Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1179-1185

  Geiger, Thomas ^a   Müller, Marcel ^a   Monia, Brett P ^b   Fabbro, Doriano ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; DOXORUBICIN; MITOMYCIN C; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER TRANSPLANTATION; COLON CANCER; DRUG POTENTIATION; FEMALE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MITOMYCIN; NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENES; THIONUCLEOTIDES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 1842403513     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Milligan, J. F., Matteucci, M. D., and Martin, J. C. Current concepts in antisense drug design. J. Med. Chem., 36: 1923-1927, 1993.
2. Crooke, S. T. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol., 32: 329-335, 1992.
3. Crooke, S. T. Progress in antisense therapeutics. Hematol. Pathol. 9: 59-72, 1995.
4. Crooke, S. T., and Bennett, C. F. Progress in antisense oligonucleotide therapeutics. Annu. Rev. Pharmacol. Toxicol., 36: 107-129, 1996.
5. Magnuson, N. S., Beck, T., Vahidi, H., Hahn, H., Smola, U., and Rapp, U. The raf-1 serine/threonine protein kinase. Semin. Cancer Biol., 5: 247-253, 1994.
6. Beck, T. W., Huleihel, M., Gunnell, M., Bonner, T. I., and Rapp, U. R. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic Acids Res., 15: 595-609, 1987.
7. Sithanandam, G., Kolch, W., Duh, F. M., and Rapp, U. R. Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. Oncogene, 5: 1775-1780, 1990.
8. Boulikas, T. The phosphorylation connection to cancer. Int. J. Oncol., 6: 271-278, 1995.
9. Powis, G., and Alberts, D. S. Inhibiting intracellular signalling as a strategy for cancer chemoprevention. Eur. J. Cancer, 30: 1138-1144, 1994.
10. Monia, B. P., Johnston, J. F., Geiger, T., Müller, M., and Fabbro, D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med., 2: 668-675, 1996.
11. Evans, B. D., Mith, I. E., Shorthouse, A. J., and Millar, J. J. A comparison of the response of human lung cell carcinoma to vindesine and vincristine. Br. J. Cancer, 45: 466-468, 1982.
12. Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., and Bennett, C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem., 266: 18162-18171, 1991.
13. Blagosklonny, M. V., and Neckers, L. M. Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs. Anti-Cancer Drug Des., 5: 437-442, 1994.
14. Stull, R. A., Zon, G., and Szoka, F. C. Single-stranded phosphodiester and phosphorothioate oligonucelotides bind actinomycin D and interfere with tumor necrosis factor-induced lysis in the L929 cytotoxicity assay. Antisense Res. Dev., 3: 295-300, 1993.
15. Schwartz, G. K., Haimovitz-Friedman, A., Dhupar, S. K., Ehleiter, D., Maslak, P., Lai, L., Lagunzo, F., Kelsen, D. P., Fuks, Z., and Albino, A. P. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J. Natl. Cancer Inst., 87: 1394-1401, 1995.
16. Blagosklonny, M. V., Giannakakou, P. El-Deiry, W. S., Kingston, D. G. L. Higgs, P. I., Neckers, L., and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57: 130-135, 1997.
17. Wang, H. G., Rapp, U. R., and Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87: 629-638, 1996.
18. Monia, B. P., Sasmor, H., Johnston, J. F., Freier, S. M., Lesnik, E. A., Müller, M., Geiger, T., Altmann, K-H., Moser, H., and Fabbro, D. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc. Natl. Acad. Sci. USA. 93: 15481-15484, 1996.
19. O'Brien, S. G., Kirkland, M. A., Melo, J. V., Rao, M. H., Davidson, R., McDonald, C., and Goldman, J. M. Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines. Leukemia (Baltimore), 8: 2156-2162, 1994.
20. Perez, J. R., Li, Y., Stein, C. A., Majumder, S., van Oorschot, A., and Narayana, R. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligonucleotides. Proc. Natl. Acad. Sci. USA, 91: 5957-5961, 1994.
21. Wyatt, J. R., Vickers, T. A., Roberson, J. L., Buckheit, R. W., Klimkait, T., DeBaets, E., Davis, P. W., Rayner, B., and Ecker, D. J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA, 91: 1356-1360, 1994.
22. Yaswen, P., Stampfer, M. R., Ghosh, K., and Cohen, J. S. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev., 3: 67-77, 1993.
23. Crooke, S. T., and Bennett, C. F. Progress in antisense oligonucleotide therapeutics. Annu. Rev. Phannacol. Toxicol. 36: 107-129, 1996.